Overview
Sex cord stromal tumors are a category of ovarian neoplasms that arise from the sex cords and stromal components of the developing gonad, including granulosa cells, theca cells, Sertoli cells, Leydig cells, and fibroblasts. These tumors account for a small fraction of all ovarian malignancies and encompass diverse subtypes with varying clinical presentations and hormonal activity. Research published in Hematology and Oncology Research has examined specific rare variants within this tumor category, including steroid cell tumors of the ovary that do not fit into well-defined subcategories. A 2022 case report and literature review explored the clinical presentation, diagnostic challenges, and management of non-specific steroid cell tumors, which represent an uncommon subtype characterized by cells resembling steroid-hormone-producing cells but lacking features of more specific entities like Leydig cell tumors or adrenal rest tumors. Understanding these rare variants matters because their rarity can lead to diagnostic uncertainty, and their potential for hormone production may cause virilization or other endocrine manifestations that significantly affect patient quality of life. Accurate characterization of these tumors informs appropriate surgical and medical management strategies.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.